Element List |
Explanation |
Increase (Decrease) in Net Profit for Current Year Compared to Last Year is Attributed to |
The decrease in net profit is due to stopping the capitalization of the costs of two production lines at one of the Company's subsidiaries (the Plant of AJA Pharmaceutical Industries Company Ltd.) as a result of commencing the commercial production and increase in the selling & marketing and general & administrative expenses. In addition to the increase in financing costs resulting from obtaining additional bank facilities and increase in the provisions for doubtful debts and zakat. |
Basis of the External Auditor's Opinion |
Unmodified opinion |
Reclassification of Comparison Items |
Certain figures of comparatives have been reclassified to conform to the presentation of the current year's financial statements. |
Comments